Current Pharmaceutical Biotechnology

2.7k papers and 53.1k indexed citations i.

About

The 2.7k papers published in Current Pharmaceutical Biotechnology in the last decades have received a total of 53.1k indexed citations. Papers published in Current Pharmaceutical Biotechnology usually cover Molecular Biology (1.1k papers), Oncology (206 papers) and Pharmacology (185 papers) specifically the topics of RNA Interference and Gene Delivery (147 papers), Monoclonal and Polyclonal Antibodies Research (121 papers) and Nanoparticle-Based Drug Delivery (97 papers). The most active scholars publishing in Current Pharmaceutical Biotechnology are Seyed Fazel Nabavi, Zeno Földes‐Papp, Younes Ghasemi, Paola Frati and Beniamin Oskar Grabarek.

In The Last Decade

Fields of papers published in Current Pharmaceutical Biotechnology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Current Pharmaceutical Biotechnology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Current Pharmaceutical Biotechnology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Current Pharmaceutical Biotechnology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Current Pharmaceutical Biotechnology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025